Literature DB >> 17652790

Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.

Jason G D Gall1, Alena Lizonova, Damodar EttyReddy, Duncan McVey, Mohammed Zuber, Imre Kovesdi, Barbara Aughtman, C Richter King, Douglas E Brough.   

Abstract

Expression of certain transgenes from an adenovirus vector can be deleterious to its own replication. This can result in the inhibition of virus rescue, reduced viral yields, or, in the worst case, make it impossible to construct a vector expressing the inhibiting transgene product. A gene regulation system based on the tet operon was used to allow the rescue and efficient growth of adenovectors that express transgenes to high levels. A key advantage to this system is that repression of transgene expression is mediated by the packaging cell line, thus, expression of regulatory products from the adenovector are not required. This provides a simple, broadly applicable system wherein transgene repression is constitutive during vector rescue and growth and there is no effect on adenovector-mediated expression of gene products in transduced cells. Several high-level expression vectors based on first- and second-generation adenovectors were rescued and produced to high titer that otherwise could not be grown. Yields of adenovectors expressing inhibitory transgene products were increased, and the overgrowth of cultures by adenovectors with nonfunctional expression cassettes was prevented. The gene regulation system is a significant advancement for the development of adenovirus vectors for vaccine and other gene transfer applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652790     DOI: 10.1007/bf02686012

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  24 in total

1.  Characteristics of adenovirus-mediated tetracycline-controllable expression system.

Authors:  H Mizuguchi; T Hayakawa
Journal:  Biochim Biophys Acta       Date:  2001-11-07

2.  Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

Authors:  T J Wickham; E Tzeng; L L Shears; P W Roelvink; Y Li; G M Lee; D E Brough; A Lizonova; I Kovesdi
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.

Authors:  N Mittereder; K L March; B C Trapnell
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5.

Authors:  W J McGrory; D S Bautista; F L Graham
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

5.  Adenovirus vector designed for expression of toxic proteins.

Authors:  D Edholm; M Molin; E Bajak; G Akusjärvi
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Presumptive identification of common adenovirus serotypes by the development of differential cytopathic effects in the human lung carcinoma (A549) cell culture.

Authors:  S M Lipson; I A Poshni; R L Ashley; L J Grady; Z Ciamician; S Teichberg
Journal:  FEMS Microbiol Lett       Date:  1993-10-15       Impact factor: 2.742

7.  Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression.

Authors:  S X Hu; W Ji; Y Zhou; C Logothetis; H J Xu
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

8.  Phosphorylation of the adenovirus DNA-binding protein and epitope mapping of monoclonal antibodies against it.

Authors:  V Cleghon; A Piderit; D E Brough; D F Klessig
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

9.  Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo.

Authors:  L L Shears; M R Kibbe; A D Murdock; T R Billiar; A Lizonova; I Kovesdi; S C Watkins; E Tzeng
Journal:  J Am Coll Surg       Date:  1998-09       Impact factor: 6.113

10.  Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells.

Authors:  F Yao; T Svensjö; T Winkler; M Lu; C Eriksson; E Eriksson
Journal:  Hum Gene Ther       Date:  1998-09-01       Impact factor: 5.695

View more
  9 in total

1.  Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.

Authors:  Diane L Bolton; Kaimei Song; Georgia D Tomaras; Srinivas Rao; Mario Roederer
Journal:  Vaccine       Date:  2016-12-29       Impact factor: 3.641

2.  Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge.

Authors:  D L Bolton; K Song; R L Wilson; P A Kozlowski; G D Tomaras; B F Keele; R V Lovingood; S Rao; M Roederer
Journal:  Mucosal Immunol       Date:  2011-10-26       Impact factor: 7.313

3.  Characterization of human adenovirus 35 and derivation of complex vectors.

Authors:  Duncan McVey; Mohammed Zuber; Damodar Ettyreddy; Christopher D Reiter; Douglas E Brough; Gary J Nabel; C Richter King; Jason G D Gall
Journal:  Virol J       Date:  2010-10-19       Impact factor: 4.099

4.  Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.

Authors:  Shannon Kraft; Chi Hsu; Douglas E Brough; Hinrich Staecker
Journal:  Laryngoscope       Date:  2013-03-11       Impact factor: 3.325

5.  Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

Authors:  Chad J Roy; Alida Ault; Satheesh K Sivasubramani; J Patrick Gorres; Chih-Jen Wei; Hanne Andersen; Jason Gall; Mario Roederer; Srinivas S Rao
Journal:  Respir Res       Date:  2011-11-21

6.  Selective atonal gene delivery improves balance function in a mouse model of vestibular disease.

Authors:  C Schlecker; M Praetorius; D E Brough; R G Presler; C Hsu; P K Plinkert; H Staecker
Journal:  Gene Ther       Date:  2011-04-07       Impact factor: 5.250

7.  Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates.

Authors:  Diane L Bolton; Sampa Santra; Cindy Swett-Tapia; Jerome Custers; Kaimei Song; Harikrishnan Balachandran; Linh Mach; Hussein Naim; Pamela A Kozlowski; Michelle Lifton; Jaap Goudsmit; Norman Letvin; Mario Roederer; Katarina Radošević
Journal:  Vaccine       Date:  2012-06-22       Impact factor: 3.641

8.  A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy.

Authors:  Ahmed O Hassan; Igor P Dmitriev; Elena A Kashentseva; Haiyan Zhao; Douglas E Brough; Daved H Fremont; David T Curiel; Michael S Diamond
Journal:  Cell Rep       Date:  2019-09-03       Impact factor: 9.423

9.  Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent.

Authors:  Sara E Bodbin; Chris Denning; Diogo Mosqueira
Journal:  Methods Protoc       Date:  2020-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.